Dinaciclib in Treating Patients With Stage IV Melanoma (NCT00937937)

🧪 Interventions in This Study

• Dinaciclib (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (190 Sites)

Showing the first 25 of 190 sites.

• Providence Hospital — Mobile, Alabama
• Mercy Hospital Fort Smith — Fort Smith, Arkansas
• University of Arkansas for Medical Sciences — Little Rock, Arkansas
• Highlands Oncology Group - Rogers — Rogers, Arkansas
• East Bay Radiation Oncology Center — Castro Valley, California
• Eden Hospital Medical Center — Castro Valley, California
• Valley Medical Oncology Consultants-Castro Valley — Castro Valley, California
• Bay Area Breast Surgeons Inc — Emeryville, California
• Valley Medical Oncology Consultants-Fremont — Fremont, California
• Contra Costa Regional Medical Center — Martinez, California
• El Camino Hospital — Mountain View, California
• Wilma Chan Highland Hospital — Oakland, California
• Alta Bates Summit Medical Center - Summit Campus — Oakland, California
• Bay Area Tumor Institute — Oakland, California
• Hematology and Oncology Associates-Oakland — Oakland, California
• Tom K Lee Inc — Oakland, California
• UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
• Valley Care Health System - Pleasanton — Pleasanton, California
• Valley Medical Oncology Consultants — Pleasanton, California
• Doctors Medical Center- JC Robinson Regional Cancer Center — San Pablo, California
• Poudre Valley Hospital — Fort Collins, Colorado
• Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut
• Boca Raton Comprehensive Cancer Center — Boca Raton, Florida
• Orlando Health Cancer Institute — Orlando, Florida
• Memorial Health University Medical Center — Savannah, Georgia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Acral Lentiginous Melanoma

• Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease — Houston, Texas
• A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma — Birmingham, Alabama
• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases — Birmingham, Alabama

Explore by condition: All Acral Lentiginous Melanoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.